Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mark A. Stang who wrote (7241)	4/17/1998 10:54:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 23519

Mark.....Welcome back to the long view....In the expanding ED markeplace Vivus has the potential for $200+ mill sales in 1999 with the capacity of the new plant. I think this will become clearer in the 3rd qtr 98....Based on future earnings they can hit $40 later this year and go higher in 1999 with the expansion that the Ireland plant will bring in YR 2000. It is may seem like a dream to many right now...time will tell. Pfe wil bring in the ED population looking for treatment...Muse and Muse II in 1999 will provide the solution for those that are not satisfied or can not use Viagara.